
Biotech raises a €31.5m seed round to develop mRNA therapeutics
SRTD Biotech has announced the successful completion of an oversubscribed €31.5 million seed financing round. The financing was led by Mérieux Equity Partners, with NRW.BANK and Boehringer Ingelheim Venture Fund joining the syndicate as co-leads. Lilly Ventures, HTGF, and the Freiburg-based family Office Anobis Asset also participated… Read More















